Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VORICONAZOLE USP, with a corresponding US DMF Number 25707.
Remarkably, this DMF maintains an Active status since its submission on December 20, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 23, 2014, and payment made on September 03, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II